BARCLAYS PLC - X4 PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$417
+145.3%
382,134
+334.8%
0.00%
Q2 2023$17087,879
+87779.0%
0.00%
Q2 2022$0
-100.0%
100
-98.7%
0.00%
Q1 2022$14,000
-61.1%
7,804
-50.0%
0.00%
Q4 2021$36,000
-30.8%
15,608
+57.7%
0.00%
Q3 2021$52,000
-51.4%
9,899
-39.7%
0.00%
Q2 2021$107,000
-41.5%
16,410
-22.8%
0.00%
Q1 2021$183,000
+120.5%
21,245
+63.5%
0.00%
Q4 2020$83,000
+8200.0%
12,993
+9180.7%
0.00%
Q2 2020$1,000
-99.5%
140
-99.2%
0.00%
Q4 2019$188,000
+154.1%
17,563
+200.1%
0.00%
Q3 2019$74,000
+1750.0%
5,852
+2288.6%
0.00%
Q1 2019$4,0002450.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 311,490$532,0001.65%
Bain Capital Life Sciences Investors, LLC 6,389,436$10,926,0001.30%
Tri Locum Partners LP 2,504,006$4,282,0001.18%
Sio Capital Management, LLC 1,418,461$2,426,0000.77%
NEA Management Company, LLC 6,523,157$11,155,0000.56%
AIGH Capital Management LLC 997,719$1,706,0000.53%
Parkman Healthcare Partners LLC 950,000$1,625,0000.46%
New Leaf Venture Partners, L.L.C. 335,000$573,0000.34%
Worth Venture Partners, LLC 250,144$428,0000.26%
Ikarian Capital, LLC 568,612$973,0000.19%
View complete list of X4 PHARMACEUTICALS INC shareholders